Nisreen Amayiri, MD
King Hussein Cancer Center
Dr. Amayiri is an Associate Professor at King Hussein Cancer Center (KHCC)/Jordan and in charge of the pediatric Neuro-Oncology service since her appointment in 2011. She completed her Pediatric Hematology/Oncology fellowship from KHCC and then received the Long-Term International Fellowship Award from CCF/ASCO which enabled her to complete her pediatric Neuro-Oncology fellowship from the Hospital for Sick Children (Sickkids)/Toronto. Dr Amayiri’s main clinical interest is to improve the survival and quality-of-survival of children diagnosed with CNS tumors in the Low- and Middle-Income countries. For the last ten years, she is coordinating a monthly pediatric Neuro-Oncology video-teleconference with Sickkids to discuss management of children with CNS tumors. This has been a valuable educational activity for the regional pediatric oncologists. In 2019, she received a 3-year grant from My-Child-Matters program to lead and develop a “HeadSmart Jordan campaign” to allow early detection of brain tumors in children. There have been many educational awareness activities as part of this campaign directed to the public, medical students, and to practicing health professionals.
Konstantinos Arnaoutakis, MD, FACP
University of Arkansas for Medical Sciences
Dr. Arnaoutakis is an Associate Professor of Medicine in the Division of Hematology and Oncology at the University of Arkansas for Medical Sciences (UAMS) and specialized in the treatment of thoracic malignancies. He became the program director of the Hematology/Oncology Fellowship two years ago. He has committed himself to continuous learning and education, and has benefitted significantly from the ASCO resources and committees (such as the ASCO PD retreat, Professional Development Committee, ASCO SEP Item Writing Task Force, ASCO eLearning Review Panel etc.). These experiences made him interested in simulation, resilience, and communication skills. The latter has been a particular interest of his, and he was a facilitator in a program that was based on the Academy of Communication in Healthcare curriculum. He was part of 12 facilitators in our institution and we trained close to 1,000 employees over three years.
Debra Brandt, DO
Jupiter Medical Center
Dr. Brandt completed her fellowship in medical hematology and oncology at Yale University, after which she worked in a private practice serving an underserved semi-rural and rural community. During that time, she started a successful clinical research program, served on many committees at the local hospital, including the board, cancer committee, and helped create a community care center. Ten years ago, she sold her practice to Yale University. During her tenure, she continued to see patients in her community as well served as the local medical director and was instrumental in converting our research program, and assisted in the start of community physicians participating in the teaching of medical students, residents, and fellows. She participated on the NCCN guideline anti-emetic committee, breast team and was on the faculty advisory committee. In 2019, she was able to participate in a one-year education fellowship. In 2021, Dr. Brandt joined Jupiter Medical Center, Florida where in addition to patient care, she works as Medical Director, building a research program and creating an affiliation with the University of Florida. Her current focus is breast and gynecologic and thoracic malignancies. Over the years, she believes that it has become increasingly difficult to care for the oncology patient. Not only is keeping up with the latest developments overwhelming, but making certain to educate the team of mid-levels, infusion and triage RNs, staff and patients has become even more challenging. She is optimistic that participation in the ASCO education fellowship will help me help others develop tools to assist in the rapidly changing environment of cancer care.
Jacqueline Brown, MD
Dr. Brown is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University with a clinical focus on genitourinary malignancies. She attended medical school at the University of Rochester School of Medicine and Dentistry. She completed an internal medicine residency at the University of Virginia, followed by hematology and medical oncology fellowship at Emory University, serving as both Chief Resident and Chief Fellow, respectively. She has been the recipient of the Mulholland Teaching Award in 2016, awarded to one trainee each year at UVA, the James Earnest Kindred Award as the resident who most influenced the graduating medical school Class of 2018, and the Most Outstanding Fellow Award in 2020 from the Emory University internal medicine residency program. Beyond her clinical research which focuses on novel therapeutic strategies in GU malignancies with a special focus on strategies in older patients, she serves as Core Faculty for the fellowship program and director of the medical oncology curriculum for internal medicine residents at Emory.
Megan Dupuis, MD, PhD
Vanderbilt University Medical Center
Dr. Dupuis is an Assistant Professor of Hematology and Oncology at Vanderbilt University Medical Center, as well as one of the Associate Program Directors for the heme/onc fellowship program. She completed her fellowship training at MD Anderson Cancer Center in 2021, where she served as Chief Fellow for education in her second and third years. Now as an APD at Vanderbilt, she has served as co-chair of the recruitment committee and developed a novel journal club curriculum which was presented at ASCO 2022. She is passionate about Narrative Medicine and is the co-creator of a new GME certificate program in the Medical Humanities. In her spare time, she volunteers as a group leader for Narrative Medicine instruction at the medical school, as a facilitator for the Finding Meaning in Medicine program, is a member of the Women in Medicine consortium at VUMC, and is an incoming member of the Tennessee Oncology Practice Society Board.
Allison Garda, MD
Mayo Clinic Radiation Oncology
Dr. Garda is a Senior Associate Consultant and Assistant Professor in the Department of Radiation Oncology at Mayo Clinic in Rochester, MN. She received her medical degree from the University of Virginia in Charlottesville, Virginia, and completed her Radiation Oncology residency at Mayo Clinic in Rochester, Minnesota. Her clinical focus is on the treatment of gynecologic and breast malignancies. Her research focuses on quality of life during radiotherapy, survivorship, biomarkers for risk stratification and individualized treatment, novel treatment strategies including advanced radiotherapy modalities, and radiation oncology inclusion in the medical school curricula. She is passionate about education, including medical education, global oncology, and patient education. She serves as Assistant Program Director for the Mayo Clinic Radiation Oncology residency program and Program Director of the Advanced Radiation Oncology and Global Oncology fellowships. She is a member of the NRG cervix and vulva subcommittee and chairs the Mayo Clinic Radiation Oncology Patient Education Committee.
Richard D. Hall, MD, MS
University of Virginia
Dr. Hall is a native of Texas, where he attended Texas A&M University and completed medical school at the University of Texas Southwestern in Dallas. He completed his internal medicine residency at the University of Virginia in 2010 and went on to serve as a chief resident at UVA in 2010-2011. Dr. Hall completed his fellowship training at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, in 2014. As a fellow, he attended the American Association for Cancer Research Molecular Biology Workshop in Snowmass, CO, and completed a Master of Science degree in clinical and translational research at the University of South Florida.
Dr. Hall joined the UVA School of Medicine faculty and UVA Cancer Center in 2014. He specializes in the treatment of thoracic malignancies, including non-small-cell lung cancer, small-cell lung cancer, thymic malignancies and mesothelioma. His primary research focus is the application of novel therapeutics, including immunotherapy, antibody drug conjugates, tyrosine kinase inhibitors and combination therapies for the treatment of lung cancer. Dr. Hall has been the UVA principal investigator on multiple lung cancer clinical trials since joining the faculty. In addition to his clinical work, Dr. Hall is involved in the educational leadership of the internal medicine residency program and became the hematology/oncology fellowship program director in August 2017.
Laura Huppert, MD
University of California, San Francisco
Dr. Huppert is an Assistant Professor and breast medical oncologist at the University of California, San Francisco (UCSF). She earned her medical degree at Harvard Medical School and then completed Internal Medicine Residency and Chief Residency and Hematology/Oncology Fellowship at UCSF. She is interested in breast cancer clinical research and medical education. She wrote an internal medicine handbook for trainees called Huppert’s Notes, which was published by McGraw Hill in 2021. She has researched the effects of virtual interviewing on the residency and fellowship application process, in terms of both applicant and program perspectives with an emphasis on how it affects diversity at training programs. She is the UCSF Internal Medicine residency Hematology/Oncology subspecialty advisor and organizes a fellowship preparation series for residents. In terms of her breast cancer research, she runs clinical trials for patients with early-stage and metastatic breast cancer, with a particular focus on novel therapies for patients with brain metastases and leptomeningeal disease. She participates in the Bay Area Breast Cancer Forum to discuss novel therapies with patients with breast cancer and is an expert content reviewer for the patient-centered website MBCbrainmets.org.
Perry Morocco, MD
University of Chicago
Dr. Morocco earned his medical degree at the Northwestern University Feinberg School of Medicine before completing his pediatric residency at Saint Louis University Cardinal Glennon Children’s Hospital, where he then served as Chief Resident. Following this, he completed his pediatric hematology-oncology fellowship at the University of Chicago’s Comer Children’s Hospital, where he will be joining the faculty as an Assistant Professor. Throughout his medical training, Dr. Morocco has been passionate about medical education, making this the focus of his fellowship scholarly project, where he developed, implemented, and taught a resident-focused curriculum for residents on the inpatient service. To expand his knowledge of curriculum design and development, he participated in the Medical Education Research, Innovation, Teaching, and Scholarship (MERITS) Program through the University of Chicago. He is excited to continue to refine his medical education skills during the ASCO Educational Scholars Program.
Lori J. Rosenstein, MD
Gundersen Health System
Dr. Rosenstein is a hematologist/oncologist and the Medical Oncology Fellowship Program Director at Gundersen Health System in La Crosse, Wisconsin. She earned her undergraduate and medical school degrees from the University of Wisconsin--Madison. She completed both internal medicine residency and hematology-oncology fellowship at the University of Iowa before accepting a staff position there and was the Medical Director of Hematology. She was a participant in the American Society of Hematology Clinical Research Training Institute and is a member of the Alliance Community Oncology and Symptom Intervention Committees. Clinically, she cares for patients with malignant and classical hematologic disorders.
Promoting excellence in medical education has been a driving interest throughout Dr. Rosenstein's career. She acted as both a chief resident and chief fellow during her own training. As a staff doctor at University of Iowa Hospital and Clinics (UIHC), she served as the Associate Program Director of the hematology and oncology fellowship program. She has won Faculty Teacher of the Year awards at both UIHC and Gundersen Health System. Since moving to Gundersen, she has been an advocate for the role of community-based health systems in medical education, serving on the ASCO Oncology Training Programs Committee and giving invited presentations at ASCO and ASH.
Ramy Sedhom, MD
Dr. Sedhom is currently in the second year of his first faculty job with Penn Medicine following training in medical oncology at Johns Hopkins and palliative care & hospice fellowship at Memorial Sloan Kettering. Clinically, he sees patients with solid tumors at a Penn Medicine satellite in Princeton, NJ – where he also serves as clinical director of palliative care. His research interests are in geriatric oncology and palliative care delivery (not just the physical components, but how to address the various domains of patient/caregiver distress). He loves volunteering with ASCO – and serve on the Trainee & Early Career Council, the Supportive Care Guideline Committee, and co-lead the Palliative Care Communities of Practice. Outside of work, he is proudest when he is called “dad” to Alexandra (turning 3) and Noah (turning 1). Also relevant, since it has influenced decisions in his career path, he is a first-generation immigrant.
Marios-Konstantinos Tasoulis, MD, PhD, FRCS
The Royal Marsden Hospital
Dr. Tasoulis is a Consultant Breast Surgeon at The Royal Marsden Hospital and Honorary Clinical Senior Lecturer at the Institute of Cancer Research in London, United Kingdom.
Dr. Tasoulis earned his MD and PhD from the National and Kapodistrian University of Athens, Greece. After completing his surgical training, he was awarded a fellowship from the European Society of Surgical Oncology (ESSO) and visited the Breast Unit at Yale University before joining The Royal Marsden Hospital.
Dr. Tasoulis has a demonstrated interest in medical education. He is the lead trainer and educational supervisor at The Royal Marsden Hospital for the National Advanced Training in Oncoplastic Breast Surgery Fellowship and the general surgery trainees rotating in breast surgery. He is faculty on the Royal College of Surgeons of England courses and was admitted in the Faculty of Surgical Trainers of The Royal College of Surgeons of Edinburgh. Dr. Tasoulis has served as a member of the ASCO Trainee Council (2017-2018) and he is actively involved in mentoring young oncology professionals through the ASCO Virtual Mentoring Program.
Dr. Tasoulis specializes in oncoplastic breast surgery with a special interest in surgery after neoadjuvant chemotherapy and management of breast implant-associated anaplastic large cell lymphoma. He is actively involved in clinical research and his main interest includes the de-escalation of breast and axillary surgery in patients with exceptional response to neoadjuvant chemotherapy.